REVIVE Webinar: The role of investigator initiated clinical trials in advancing antimicrobial use

Speakers:

• Anouk G. Overdevest, MD, Amsterdam UMC (The Netherlands)
• Jesús Rodríguez-Baño, Professor of Medicine, University of Seville (Spain)
• Nicholas A. Turner, Assistant Professor, Division of Infectious Diseases, Duke University School of Medicine (USA)

Moderator: Steven Tong, Professor of Infectious Diseases, University of Melbourne (Australia)

This webinar will feature leading investigators of clinical trials presenting how evidence generation can support more effective, sustainable and accessible use of antibiotics in the context of rising antimicrobial resistance.

Presentation 1: One day versus 4-7 days of antibiotic treatment in patients with acute cholangitis after adequate biliary drainage (COBRA): a multicenter, open-label, non-inferiority randomised controlled trial (Anouk G. Overdevest)

Presentation 2: Dalbavancin as an Option for Treatment of S. aureus Bacteremia: the DOTS Trial (Nicholas A. Turner)

Presentation 3: ASTARTÉ trial: reviving temocillin as a carbapenem-spare drug.

This webinar is done in collaboration with the CLARITY initiative.

Date and time:
Tue, Sep 29, 2026 1:30 PM – 3:00 PM CEST

Dedicated registration link here